MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.carrev.2021.08.004

Медицинская библиотека · Cardiovascular revascularization medicine : including molecular interventions · 2021

Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry.

Honda Yohsuke, Yamawaki Masahiro, Nakano Takahide, Makino Kenji, Ito Yoshiaki, Yashima Fumiaki, Tada Norio, Naganuma Toru, Yamanaka Futoshi, Mizutani Kazuki, Tabata Minoru, Ueno Hiroshi, Takagi Kensuke, Watanabe Yusuke, Yamamoto Masanori, Shirai Shinichi, Hayashida Kentaro, OCEAN-TAVI Investigators

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Access-site complications during transfemoral transcatheter aortic valve implantation (TF-TAVI) cause serious issues in the future, if unresolved, but the best strategies to manage these complications remains unclear. This study aimed to comprehensively assess access-site complications during percutaneous TF-TAVI in terms of their management.

METHODS

Using the prospective, multicentre, observational registry OCEAN (Optimized Transcatheter Valvular Intervention), 1497 patients who underwent percutaneous TF-TAVI between October 2013 and May 2017 were identified. The incidence, predictors, temporal changes, and prognosis of access-site complications along with its treatment strategy and re-intervention rate were evaluated.

RESULTS

Access-site complications occurred in 105 patients (7.0%) and was predicted with lower body-mass-index (OR, 0.94; 95% CI; 0.89-0.99; p = 0.03) and higher sheath-to-femoral-artery-ratio (OR, 1.12; 95% CI, 1.03-1.24; p < 0.002). The incidence of access-site complications declined over time, irrespective of the increasing number of percutaneous TF-TAVI cases. Access-site complications were treated by conservative therapy (n = 19, 18%), interventional procedures (n = 42, 40%), rescue surgical repair (SR) (n = 10, 10%), and primary SR (n = 34, 32%). The severity of complications differed but the re-intervention rate was similar among 4 groups (p = 0.46). Re-intervention was not needed, except for a case of common femoral artery stenosis/occlusion induced by ProGlide. The need for all SRs decreased annually. Access-site complications were not associated with 30 days- and 1 year-survival rate.

CONCLUSIONS

The incidence of access-site complications was not low but has declined annually. Access-site complications are not related to worse outcomes after successful management. Interventional procedure is acceptable as the first-line strategy to treat access-site complications.

Для цитирования: Honda Yohsuke, Yamawaki Masahiro, Nakano Takahide, Makino Kenji, Ito Yoshiaki, Yashima Fumiaki, Tada Norio, Naganuma Toru, Yamanaka Futoshi, Mizutani Kazuki, Tabata Minoru, Ueno Hiroshi, Takagi Kensuke, Watanabe Yusuke, Yamamoto Masanori, Shirai Shinichi, Hayashida Kentaro, OCEAN-TAVI Investigators. Successfully Managed Access-Site Complication Was Not Associated With Worse Outcome After Percutaneous Transfemoral Transcatheter Aortic Valve Implantation: Up-to-Date Insights From the OCEAN-TAVI Registry.. Cardiovascular revascularization medicine : including molecular interventions. 2021. DOI: 10.1016/j.carrev.2021.08.004.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.